Will’s background is in digital health and healthcare consulting with the NHS. He joined Big Health in 2019 and leads their partnerships with the NHS to make Sleepio (for insomnia), Daylight (for generalised anxiety disorder), and Spark (for depression) available to patients nationwide.
In May 2022, Sleepio became the first-ever digital therapeutic to receive positive guidance from the National Institute for Health and Care Excellence (NICE) in following evaluation of Sleepio’s clinical and health economic evidence base, delivered in partnership with NHS teams and Health Innovation Oxford and Thames Valley.
11:20am: Harnessing technology for mental well-being – Trends, trials, and triumphs